Stallergens

Stallergenes Greer is a global healthcare company specializing in the diagnosis and treatment of allergies through the development and commercialization of allergen immunotherapy (AIT) products and services. The company offers a comprehensive portfolio of sublingual (drops and tablets) and subcutaneous treatments tailored to individual patient needs. Its flagship products include Actair, Oralair, and Staloral, which target common allergens such as dust mites, grass pollens, and birch pollens. Stallergenes Greer operates across the entire value chain, from allergen production to clinical development and distribution, aiming to provide long-term relief for patients suffering from allergic rhinitis and asthma.